Teleflex's vascular positioning device wins FDA nod

04/29/2013 | RTT News

The FDA has cleared Teleflex to market its ARROW VPS G4 Device, which could be released in the U.S. during the second quarter of the year. The system is said to be the only such device designed to pinpoint the exact site of the lower 1/3 of the vena cava and cavo-atrial junction using micro-Doppler ultrasound combined with advanced algorithms and intravascular ECG.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC